Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

DEXTROSE AND SODIUM CH

Active
SPE2DP-26-T-4324Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Dextrose and Sodium Chloride Injection USP is a sterile, nonpyrogenic, single-dose intravenous solution containing 5 grams of anhydrous dextrose and 0.45 grams of sodium chloride per 100 mL, packaged in 1-liter bags with one port, and is latex-free but contains DEHP. Each package contains twelve 1-liter containers, and the product must be stored at 20 to 25°C with protection from excessive heat and freezing; it must not be used if the solution is cloudy or seals are compromised. The item is regulated by the FDA, has a non-extendable shelf life of 30 months, and must be marked in accordance with Medical Marking Standard No. 1 and MIL-STD-129. Packaging must comply with DLA’s RP001 requirements and ASTM D3951 if nonhazardous, with all DLA technical requirements taking precedence. The unit of issue is a box (BX), with one box containing twelve 1-liter bags, and delivery is required within ten days FOB destination to the specified address in Baumholder, Germany. The procurement is under solicitation SPE2DP-26-T-4324, with a required delivery date of July 29, 2026, and the National Stock Number is 6505-00-116-1025. The product is identified by NDC 00990-7926-09 and provided by ICU Medical Sales, Inc. Government use documentation and compliance with DLA procurement standards are mandatory, including referral through EBS and adherence to all applicable DLA Master List requirements, with point of contact for inquiries listed as Daniel Porter.

General Info

1-liter dextrose and sodium chloride IV bags, 12 per box, FOB Baumholder, delivery by July 29, 2026, NDC 00990-7926-09.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4324.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
DANIEL PORTER
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
DEXTROSE AND SODIUM CHLORIDE INJECTION
DEXTROSE AND SODIUM CHLORIDE INJECTION<(>,<)> USP. RX ONLY; STERILE AND
NONPYROGENIC. SINGLE-DOSE CONTAINER. LATEX-FREE; CONTAINS DEHP. FOR
INTRAVENOUS USE ONLY. CONTAINS ONE PORT. EACH 100 ML CONTAINS: HYDROUS
DEXTROSE USP 5 G SODIUM CHLORIDE USP 0.45 G WATER FOR INJECTION USP QS.
UNIT OF ISSUE IS A PACKAGE CONTAINING 12 EACH (BAGS/CONTAINERS). EACH
BAG OR CONTAINER CONTAINS 1,000 ML OR 1 LITER. STORE AT 20 TO 25°C (68
TO 77°F). [SEE USP CONTROLLED ROOM TEMPERATURE.] AVOID EXCESSIVE HEAT
AND PROTECT FROM FREEZING. USE ONLY IF THE SOLUTION IS CLEAR AND SEALS
ARE INTACT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
ICU MEDICAL SALES, INC. 85RR5 P/N NDC00990-7926-09
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017628327 0001 BX 1.000
SPE2DP-26-T-4324
SECTION B
PR: 7017628327 PRLI: 0001 CONT’D
NSN/MATERIAL:6505001161025
DELIVERY (IN DAYS):0010
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
WK4GA8
0240 QM CO QM SUPPORT CO (
AWCF SSF SMITH BARRACKS BLDG 8338
AULENBACHER STRASSE
BAUMHOLDER 55774
DE
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WK4GA8
0240 QM CO QM SUPPORT CO (
AWCF SSF SMITH BARRACKS BLDG 8338
AULENBACHER STRASSE
BAUMHOLDER 55774
DE
MARKFOR
WK4GA8
0240 QM CO QM SUPPORT CO (
AWCF SSF SMITH BARRACKS BLDG 8338
AULENBACHER STRASSE
BAUMHOLDER 55774
DE
M/F: (TCN) WK4GA862050022
RDD: 218
PROJ: 9GU TP 3
SPE2DP-26-T-4324
SECTION B
PR: 7017628327 PRLI: 0001 CONT’D
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A01 DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:07/29/2026
SPE2DP-26-T-4324 NSN/Part Number: 6505-00-116-1025 Quantity: 1 BX Purchase Request: 7017628327QTY: 1 Delivery: 10 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
CIPROFLOXACIN TABLETSCiprofloxacin tablets, 500 mg unit dose in packages of 100, are being procured under solicitation SPE2DP-26-T-4316 with the NSN 6505012738650, requiring a total of three units of issue, each representing 100 tablets. The item must comply with all technical and quality standards listed in the DLA Master List of Technical and Quality Requirements, including specific packaging guidelines that mandate commercial packaging consistent with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a container that protects against damage, and all shipments must be packed in commercial exterior containers suitable for safe delivery via common carrier at the lowest cost to the specified destination. The product has a non-extendable shelf life of 36 months and must bear labels and markings in full compliance with medical marking standards. The supplier, The Harvard Drug Group, L.L.C., must deliver the item FOB destination within 20 days of contract award, with no variance allowed in quantity. Inspection and acceptance occur at the delivery point, and all materials must be prepared in accordance with MIL-STD-2073-1E. The contract includes applicable defense information controls, and government identification must be removed from any non-accepted supplies. The solicitation opened on July 27, 2026, with a response deadline of August 3, 2026, and is being managed by the Department of Defense’s Medical Supply Chain PHARM FSA with direct contact through James Foggie.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
MECLIZINE HYDROCHLORIDMeclizine Hydrochloride Tablets USP, containing 25 milligrams of the active ingredient per tablet, are procured in bottles of 1,000 tablets, with a total shelf life of 24 months and a mandatory minimum of 21 months remaining at the time of receipt by the first government activity. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) as per USP standards. Packaging must comply with commercial standards and meet the Medical Marking Standard No. 1, superseding MIL-STD-129, with all containers designed to prevent damage and ensure safe transport via common carrier at the lowest cost to the destination. The item is regulated by the FDA and requires referral to a product specialist for confirmation prior to award. The contract specifies delivery to Fort Bragg, North Carolina, within 20 days, with no variance allowed in quantity. The unit of issue is a bottle (BT), and palletization must follow DLA packaging requirements. The drug is supplied by approved manufacturers including Amneal Pharmaceuticals and Jubilant Cadista, with NDC identifiers provided. The material is not classified as hazardous per Fed-Std-313 and must be commercially packaged in accordance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence. Shipments must be traceable and不得 use parcel post. The solicitation number is SPE2DP-26-T-4296, with a response deadline of August 3, 2026, and the required delivery date is July 28, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
ACYCLOVIR TABLETSThe contract pertains to the procurement of 3 bottles of 800 mg acyclovir tablets, each bottle containing 100 tablets, under solicitation SPE2DP-26-T-4323, with delivery required within 20 days FOB destination. The product must meet strict packaging standards as defined by Medical Marking Standard No. 1, superseding MIL-STD-129, and must be packed in sealed unit containers that prevent damage, with exterior shipping containers ensuring safe, cost-effective delivery via common carrier. The acyclovir tablets are sourced from approved manufacturers including Golden State, Teva, GSK Zovirax, Carlsbad Tech, and Mylan, each identified by specific NDC codes. The item carries a non-extendable 24-month shelf life as a Type I (Code M) item, and no mercury or mercury-containing compounds may be introduced into the product or packaging, except for specific exceptions such as batteries or instruments meeting NAVSEA specifications. The contract follows DLA’s master list of technical and quality requirements, and units must be marked in accordance with DLA’s medical marking guidelines. Inspection and acceptance occur at the delivery point with zero variance allowed in quantity, and the unit of issue is bottles (BT). The contract is issued under the Department of Defense, with performance located at Fort Bragg, and all documentation must align with DoD authorized unit of issue standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
LORATADINE TABLETSLoratadine tablets 10 mg are being procured in bulk quantities of 500 tablets per unit, with a total requirement of three units (BT), each containing 500 tablets, under solicitation SPE2DP-26-T-4315. The product is regulated by the FDA and must comply with strict packaging and marking standards, specifically Medical Marking Standard No. 1, which replaces all references to MIL-STD-129; packaging must be commercial grade, sealed to prevent damage, and suitable for safe transport via common carrier at the lowest cost to the destination point specified in the contract. The item has a non-extendable shelf life of 36 months and must be stored between 20°C and 25°C (68°F to 77°F), protected from excessive moisture. The manufacturer is OHM Laboratories Inc with NDC 51660-0526-05, distributed by AmerisourceBergen Drug Corp, and the NSN is 6505-01-524-9179. Delivery is required within 20 days FOB destination with zero variance allowed on quantity, and inspection and acceptance occur at the delivery point. The contract mandates compliance with DLA’s Master List of Technical and Quality Requirements, and any applicable defense information controls under RD003. All packaging must be labeled in accordance with MMS No. 1, accessible via the DLA website, and the contracting official must submit a referral in EBS to confirm bidder and manufacturer details prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
MOXIFLOXACIN HYDROCHLOMoxifloxacin Hydrochloride Tablets, 400 mg in 30-count bottles, are procured under solicitation SPE2DP-26-T-4320 with a requirement for three bottles, delivered FOB destination within 20 days. The item is regulated by the FDA and must comply with the Medical Marking Standard No. 1, superseding MIL-STD-129, with all packaging and labeling adhering strictly to its specifications. Each unit must be sealed in commercial packaging capable of preventing damage and shipped in exterior containers suitable for safe transport via common carrier at the lowest rates. The product carries a non-extendable shelf life of 36 months and must be stored at controlled room temperature away from high humidity. The supplier must be identified by NDC number—either Teva Pharmaceuticals USA Inc. NDC 00093-7387-56 or Rising Pharma Holdings Inc. NDC 57237-0156-30—and all documentation must include bidder and manufacturer details for FDA referral via EBS. The unit of issue is bottle, and no variance in quantity is permitted. Packaging must meet MIL-STD-2073-1E standards, and delivery is to Fort Stewart, GA, with inspection and acceptance occurring at destination.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
BUPIVACAINE HYDROCHLORThe contract specifies the procurement of BUPIVACAINE HYDROCHLORIDE INJECTION, USP, 0.25%, in 50 mL vials, with a total quantity of 5 bottles, to be delivered within 20 days to Fort Bragg, North Carolina. The product is regulated by the FDA and must meet strict shelf-life requirements of 24 months with no extensions, and storage must be maintained between 20 °C to 25 °C, with allowable excursions between 15 °C to 30 °C. Packaging and labeling must comply with MIL-STD-129, DLA’s Packaging Requirements for Procurement, and ASTM D3951 for non-hazardous materials, though DLA’s technical and quality requirements take precedence. The item is marked with NDC00409-1587-50 and sourced from PFIZER INC, with unit of issue BT and no variance allowed in quantity. Delivery is FOB destination, with inspection and acceptance occurring at the destination point. The shipment must be sent via traceable means and not parcel post. The contracting entity is the Department of Defense, under the Medical Supply Chain Pharm FSA, with the solicitation number SPE2DP-26-T-4293, and the required delivery date is July 28, 2026. All technical and quality specifications referenced in the DLA Master List are binding and must be adhered to, and the product is subject to covered defense information protocols.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
DIPHENHYDRAMINE HYDThe contract specifies the procurement of 50mg DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES,USP in 100-count bottles, with a total order of 12 bottles (5 units of 1 bottle and 7 units of 1 bottle), delivered FOB destination within 20 days of the required delivery date of July 29, 2026. The item is regulated by the FDA and carries a non-extendable 24-month shelf life under Type I (Code M) requirements. Packaging must comply with DLA’s RP001 standards, MIL-STD-129 labeling, and the DLA Master List of Technical and Quality Requirements, taking precedence over commercial standards like ASTM D3951. The product must be shipped via traceable freight without parcel post, and all packaging must indicate the manufacturer as RICHMOND PHARMACEUTICALS, INC. with NDC54738-0116-01 and be palletized per DLA directives. Delivery is directed to Fort Bragg, North Carolina, under contract SPE2DP-26-T-4313, with no variance allowed in quantity. The contract also requires strict adherence to the federal marking and hazardous material handling protocols, including the incorporation of RD003 for covered defense information and RA001 for technical and quality compliance. All documentation and submissions must reference the DLA eProcurement portal for applicable requirements, and the contracting official must submit an EBS referral to confirm product eligibility.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
LEVONORGESTREL AND ETHThe contract specifies the procurement of LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS, USP, a hormonal contraceptive medication regulated by the FDA, manufactured by TEVA PHARMACEUTICALS USA, INC. with NDC 00555-9047-58. Each unit consists of six 28-day cycles totaling 168 tablets, formulated in a sequential pattern: six tablets containing 0.050 mg levonorgestrel and 0.030 mg ethinyl estradiol, followed by five tablets with 0.075 mg levonorgestrel and 0.040 mg ethinyl estradiol, then ten tablets with 0.125 mg levonorgestrel and 0.030 mg ethinyl estradiol, concluding with seven inert tablets. The unit of issue is one package containing 168 tablets, and the product must have a minimum of 21 months of remaining shelf life upon receipt by the government, with a total shelf life of 24 months non-extendable. Storage must be maintained at controlled room temperature, between 20° and 25°C (68° to 77°F), per USP guidelines. All packaging and labeling must strictly comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must be commercially packaged to ensure protection during transport. Packaging must be sealed in suitable containers to prevent damage and delivered in commercial shipping containers at the lowest feasible freight rate to the designated delivery point at Fort Stewart, Georgia. Delivery is required within 20 days of contract award, with no variance allowed in quantity, and inspection and acceptance occur at the destination. The shipment must be sent by the fastest traceable means, excluding parcel post, and must adhere to all DLA Master List of Technical and Quality Requirements, which take precedence over other standards such as ASTM D3951. The contract is part of a federal solicitation under SPE2DP-26-T-4311, with the purchasing agency being the Department of Defense through the Medical Supply Chain Pharm FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
LABETALOL HYDROCHLORIDLabetalol Hydrochloride Injection USP, 5 mg per mL in 40 mL vials, is being procured under solicitation SPE2DP-26-T-4294 with a required delivery of four vials within twenty days to Fort Stewart, Georgia, FOB destination. Each vial is a single unit of issue and must conform to FDA regulations and the DLA Master List of Technical and Quality Requirements, including specifications outlined under RQ011, RS016, and RS001, which mandate a non-extendable shelf life of twenty-four months and proper medical marking per the latest Medical Marking Standard No. 1. The product is manufactured by Hikma Pharmaceuticals USA Inc. with NDC 00143-9623-01 and must be stored at medical controlled room temperature. The purchase request number is 7017618337, and the NSN is 6505012579990; zero variance is permitted in quantity, and inspection and acceptance occur at the delivery point. Packaging must meet MIL-STD-2073-1E standards, and all government identification must be removed from non-accepted supplies in accordance with RD003. The contracting official is required to submit a referral in EBS to the product specialist with full bidder and manufacturer details prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
IVERMECTIN TABLETSIvermectin tablets, 3 mg in unit dose, are procured in packages of 20 tablets per unit, with a total quantity of one package required under solicitation SPE2DP-26-T-4310. The product must comply with strict packaging standards as defined by Medical Marking Standard No. 1, superseding MIL-STD-129, and must be shipped in commercial-grade containers designed to prevent damage and ensure safe delivery at the lowest freight cost to Fort Bragg, North Carolina, 28310. Storage must be maintained below 30°C (86°F), and the item has a non-extendable shelf life of 24 months as a Type I (Code M) item. The tablets are regulated by the FDA and require confirmation by the product specialist via EBS referral, including full manufacturer and part number details. Two manufacturers are identified: Merck Sharp & Dohme Corp. with NDC 00006-0032-20 and Edenbridge Pharmaceuticals, LLC with NDC 42799-0806-01. Delivery is FOB destination within 20 days, with zero tolerance for quantity variance, and inspection and acceptance occur at the point of delivery. All markings, packaging, and documentation must adhere to DLA’s updated technical and quality requirements as referenced in the DLA Master List, and the item is identified by NSN 6505-01-491-9286.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
ALBUTEROL SULFATE INHA
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride 0.9% Injection, USP, 500 mL in packs of 24 units is being procured under solicitation SPE2DP-26-T-4212 by the Department of Defense’s Medical Supply Chain PHARM FSA for delivery to Prince Hassan Air Base in Safawi, Jordan. The contract requires 8 packs, with delivery due 20 days after order placement, and products must meet all FDA regulatory standards for pharmaceuticals. Packaging must follow commercial standards as specified in the procurement document, with each unit sealed in a protective container and shipped in commercial exterior containers capable of safe transportation at the lowest rate. Marking must conform to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for all medical items, and packaging must comply with MIL-STD-2073-1E. A strict 24-month non-extendable shelf life applies, and the product must be free from intentional mercury or mercury-containing compounds, except for functional uses such as batteries or sensors as permitted under NAVSEA 5100-003D. The item is subject to the FAR and DFARS clauses covering cybersecurity, information safeguarding, trafficking in persons, employment eligibility, sustainable products, and prohibition of covered telecommunications equipment. Offerors must be registered in SAM.gov, possess a valid UEI and CAGE code, and comply with socioeconomic representations including small business status. All submissions must be made electronically via the DLA Internet Bid Board System by the closing date of July 27, 2026. Inspection and acceptance occur at the destination, and payment must be requested through Wide Area WorkFlow. Contractor personnel must be informed of whistleblower rights, and any cyber incidents involving covered defense information must be reported in accordance with DFARS clause 252.204-7012. The contract prohibits the use of mandatory arbitration agreements, restricts compensation of former DoD officials, and mandates compliance with NIST SP 800-171 for information system safeguarding. The government reserves the right to reject any non-compliant offer, and the product must be manufactured by an approved vendor such as Baxter, B. Braun, or McKesson, with verified product codes and NDC numbers provided.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 2 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
EPINEPHRINE INJECTIThe contract specifies the procurement of 11 boxes of epinephrine injection USP, each containing 10 single-use 2 mL ampules with 1 mg of epinephrine, formulated without sulfites or preservatives. The product must be stored at room temperature between 20 to 25°C, protected from freezing and exposure to alkalis or oxidizing agents, and shipped without refrigeration. Each box must be sealed in a commercial container that prevents damage or breakage, and all packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. The item carries a non-extendable 18-month shelf life under TYPE I (CODE K) requirements. Hazard communication standards under OSHA’s revised Hazard Communication Standard apply, requiring suppliers to submit Safety Data Sheets and compliant labeling aligned with 29 C.F.R. 1910.1200 prior to contract award, along with employee training on updated safety protocols. Delivery is FOB destination within five days to Fort Bragg, North Carolina, via the fastest traceable means excluding parcel post. The unit of issue is a box, with exact quantity adherence—no variance permitted—and the product is identified by NSN 6505-01-667-4146 and NDC 54288-0103-10. The supplier is AmerisourceBergen Drug Corp, and the contract is governed by DLA packaging and technical requirements, with all documentation subject to federal oversight and government-only use designations.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 20 hours ago

DEADLINE

in 2 days
View Details
NAICS: 456199
New
DIBBS
LEVOFLOXACIN TABLETSLevofloxacin tablets are supplied in bottles containing 20 tablets each, with each tablet delivering 750 mg of the active ingredient, and are marked for prescription use only. The product has a total shelf life of 24 months, with a mandatory minimum of 21 months remaining at the time of receipt by the first government activity. Storage must be maintained at controlled room temperature between 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit), per USP guidelines. Labeling requirements include the National Stock Number, manufacturer name, date of manufacture, expiration or retest date, contract number, and lot number, all in compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards ensuring protection from damage, with exterior shipping containers suitable for safe delivery via common carrier at the lowest cost to the designated destination at Fort Stewart, Georgia. The unit of issue is a bottle (BT), and the contract specifies a quantity of 2 bottles. Delivery is due within 20 days of order placement, FOB destination, with no quantity variance permitted. The material is not classified as hazardous under Fed-Std-313 and must be commercially packaged in accordance with ASTM D3951, though all DLA Master List of Technical and Quality Requirements take precedence. Shipment must be sent by the fastest traceable means, excluding parcel post. The contract is issued under solicitation SPE2DP-26-T-4299 with a required delivery date of July 28, 2026, and is procured by the Department of Defense through the Medical Supply Chain Pharmaceutical FSA.
All Other Health and Personal Care Retailers

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
BACITRACIN OINTMENTBacitracin Ointment in 0.9 gram packets is being procured under contract SPE2DP-26-T-4304 with a total quantity of six boxes, each containing 144 packets, for delivery to Fort Bragg, North Carolina. The item is regulated by the FDA and must comply with all applicable DLA Master List of Technical and Quality Requirements, which supersede ASTM D3951 and other commercial packaging standards. Packaging must conform to MIL-STD-129 and RP001 standards, with unit packaging specified as one box per unit of issue and palletization following DLA guidelines. The product has a 60-month shelf life and must be stored at medical controlled room temperature. Delivery is FOB destination with zero variance allowed on quantity, inspection and acceptance occur at the destination, and shipment must occur via traceable means—parcel post is prohibited. Each shipment must include the correct military markings, and all packaging must be labeled in accordance with the Medical Marking Standard No. 1. The requirement is part of a Defense Logistics Agency solicitation for medical supply chain support, with the original delivery dates set for July 28 and 29, 2026, depending on the line item. The purchasing entity is identified as the 3D SFG SSA AWCF SSF at Fort Bragg, and all documentation must reference the NSN 6505-01-671-4147 and manufacturer part number WJBA1728-BX. The contract specifies two distinct CLINs with different purchase request numbers and assigned shipping control numbers for traceability.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details